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Abstract 
Purpose: To determine the anti-Streptococcus pyogenes activity of the chloroform extract of 
Boesenbergia pandurata (Roxb.) Schltr. (Zingiberaceae) and investigate its possible antibacterial 
mechanisms of action.  
Methods: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) 
values were investigated against 47 clinical isolates of S. pyogenes. Time-kill study was performed to 
determine how quickly the extract acts on S. pyogenes. The ability of the extract to damage bacterial 
cell wall and effects on S. pyogenes virulence factors including protease enzyme and haemolysin were 
investigated.  
Results: The extract exhibited good antibacterial activity against all of the clinical isolates of S. 
pyogenes with similar MIC and MBC ranging from 3.91-62.50 µg/ml. Complete killing of the bacterial 
cells by the extract at concentrations of 4MIC, 2MIC, and MIC occurred within 4, 8, and 12 h, 
respectively. Treatment of the bacterial cells with the extract at 2MIC and 4MIC caused cell lysis. All the 
test concentrations (1/32 - 1/2MIC) produced no effects on protease and haemolysin enzymes.  
Conclusion: Boesenbergia pandurata extract has powerful in vitro activity against S. pyogenes. The 
ability of the extract to lyse the bacterial cells suggests that the mechanism of action may be associated 
with cell wall and cell membrane damage. 
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Boesenbergia pandurata (Roxb.) Schltr. (Syn. 
Kaempferia pandurata, Boesenbergia rotunda) is 
an edible medicinal plant and spice from the 
ginger family (Zingiberaceae). This medicinal 
plant is generally used as a traditional medicine 
in Southeast Asia. The rhizome of this plant is 
widely used to treat a number of ailments such 
as gastrointestinal [1], oral, respiratory [2,3], and 
skin diseases [4]. The antimicrobial activities of 
this plant have been reported by several 
research groups. The oil from this plant showed 
inhibitory activities against bacteria [5], fungi, 
and yeasts [6]. Pinostrobin and red oil from this 
plant exhibited anti-Helicobacter pylori activity 
[7]. The chloroform extract of this plant was 
found to be effective against Gram-positive 
bacteria with high activity against S. aureus [8]. 
Panduratin A from this plant possessed a very 
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good antibacterial activity against a number of 
staphylococci and enterococci clinical isolates 
and its activity was more powerful than many 
commonly used antibiotics [9,10]. Isopanduratin 
A from this plant demonstrated antibacterial 
activity against Streptococcus mutans, 
Streptococcus sobrinus, Streptococcus 
sanguinis, and Streptococcus salivarius [11].  
 
Streptococcus pyogenes (group A streptococci), 
an important species of Gram-positive bacterial 
pathogens, can colonize the throat or skin and 
responsible for a wide variety of diseases in 
humans. S. pyogenes is the most common 
cause of bacterial pharyngitis and is the cause of 
scarlet fever and impetigo. In severe cases this 
bacterium can cause invasive diseases such as 
cellulitis, septicemia, necrotizing fasciitis, and 
streptococcal toxic shock syndrome.  S. 
pyogenes infections may leads to the delay 
sequelae of rheumatic fever and 
glomerulonephritis [12]. Increased antibiotic 
resistance in S. pyogenes [13] and antibiotic 
treatment failure for S. pyogenes infections [14] 
have been reported and become a serious 
clinical problem. The relationship between 
antibiotic consumption and resistance rate in S. 
pyogenes has been extensively investigated in 
previous study [15]. Thus, the discovery of novel 
agents for the treatment of S. pyogenes 
infections is required in the near future. Many 
medicinal plants have been studied for their 
antibacterial property and some plants have a 
strong activity and good potential to be 
developed into an effective drug. Such plants 
may substitute antibiotic consumption or 
decrease antibiotic resistant bacteria. A previous 
study found that B. pandurata extract produced 
good antibacterial activity against S. pyogenes 
[16]. However, the previous study reported the 
activity against only a single S. pyogenes isolate. 
Therefore, this present study was aimed to 
evaluate antibacterial activity of this effective 
plant against various clinical isolates of S. 







The rhizome of B. pandurata was collected during 
2007 by Dr Oratai Neamsuvan, an ethnobotanist 
of Traditional Thai Medicine, Prince of Songkla 
University, Hat Yai, Songkhla, Thailand, where a 
voucher specimen (NPRC0007) was deposited in 
the herbarium. The chloroform extract of rhizome 
of B. pandurata  was prepared according to a 
previous study [16]. Briefly, the rhizomes of the 
plant were cut into small pieces and dried at 60 
˚C. The dried rhizomes were crushed in a 
mechanical mortar and soaked with chloroform 
for 7 days. The extract was completely dried and 
dissolved in dimethyl sulfoxide (DMSO, Merck, 
Germany) before use. 
 
Bacterial isolate and culture condition 
 
Forty-seven clinical isolates of S. pyogenes 
(NPRC 101-147) from patients with tonsillitis or 
pharyngitis were obtained from Department of 
Microbiology and Natural Products Research 
Center, Faculty of Science, Prince of Songkla 
University. All isolates were susceptible to 
penicillin G (MIC range, < 0.015 - 0.062 µg/ml) 
and erythromycin (MIC range, <0.015 - 0.125 
µg/ml). All isolates were stored in brain heart 
infusion (BHI) broth containing 20 % glycerol at -
70 ˚C until use. S. pyogenes DMST 17020 was 
purchased from the National Institute of Health 
(NIH), Department of Medical Sciences, 
Ministry of Public Health, Thailand. All strains 
were routinely grown in BHI broth or blood agar 
(BA) plates and incubated with 5 % CO2 at 37 oC 




The minimum inhibitory concentration (MIC) 
values were determined by a broth microdilution 
method according to Clinical and Laboratory 
Standards Institute Guidelines [17]. The MIC of 
the extract was defined as the lowest 
concentration that produced a complete 
suppression of visible growth. Aliquots (20 µl) 
from the broth with no visible growth were 
cultured onto BA plates and incubated with 5 % 
CO2 at 37 ˚C for overnight. The minimum 
bactericidal concentration (MBC) was recorded 
as the lowest concentration completely 
preventing bacterial growth. All tests were 




A time-kill assay was used to investigate the 
bactericidal activity of the extract. The bacterial 
cultures (105 cfu/ml) in BHI broth supplemented 
with the extract at concentrations equivalent to 
1/2MIC, MIC, 2MIC, and 4MIC were incubated at 
37 ˚C. Surviving bacteria were observed every 2 
h intervals until 24 h by culturing on BA plates 
with 5 % CO2 at 37 ˚C. A control with 1 % 
DMSO was applied with the same conditions. All 
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A modified method according to Carson et al. 
[18] was used to determine the bacteriolytic 
activity of the extract. Briefly, the suspensions 
of S. pyogenes (1.5 × 108 cfu/ml) in 0.85 % 
normal saline solution were mixed with the 
extract at concentrations equivalent to 1/2MIC, 
MIC, 2MIC, and 4MIC. Then the optical density 
(OD) at 620 nm was measured every 2 h 
intervals until 12 h and 24 h. Bacterial cell lysis 
was indicated by a decrease in OD 620 nm. 
Corresponding dilutions of the extract were used 
as blanks. A control with 1 % DMSO was applied 
with the same conditions. The results were 
expressed as a ratio of the OD at each time 
interval versus the OD at 0 min (in %). All assays 
were carried out in triplicate. 
 
Enzyme and toxin inhibition assay 
 
A method from Nostro et al. [19] was modified 
and used in this experiment. The productions or 
activities of protease enzymes and haemolysins 
in the presence of the plant extract were 
estimated on 1% skim milk-BHI agar and BA, 
respectively. The extract was mixed with the 
melted test agar in order to obtain 1/2MIC, 
1/4MIC, 1/8MIC, 1/16MIC, and 1/32MIC. Five μl 
of the bacterial culture diluted to 108 cfu/ml were 
spot inoculated in radial patterns on the plate 
surfaces with and without extracts and incubated 
with 5 % CO2 at 37 ˚C for 24 h. All 
determinations were performed in duplicate 
including 1 % DMSO as control. The diameter of 
bacterial growth and clear zones (protease 
activities) on 1% skim milk-BHI agar were 
recorded and calculated as the degree of 
hydrolysis. The diameter ratio of haemolysis 
zone and colonies was calculated as the degree 
of haemolysis. Inhibition of productions or 
activities of protease enzymes and streptolysins 
were evaluated as total when the halo was 
absent and partial when the halo was ≥50 % 






Antibacterial activities of the extract against S. 
pyogenes were presented as MIC and MBC 
values. As shown in Table 1, the chloroform 
extract of B. pandurata displayed a good anti-S. 
pyogenes activities with similar MIC and MBC 
ranges, 3.91 - 62.50 µg/ml. Both MIC50 and 
MIC90 values of the extract on S. pyogenes were 
7.81 µg/ml.  
 
Table 1: The minimum inhibitory concentration (MIC) 
and minimum bactericidal concentration (MBC) of 
chloroform extract of Boesenbergia pandurata against 




Anti-S. pyogenes activity 
(µg/ml) 
 aMIC50 bMIC90 MIC range MBC range 
Boesenbergia 
pandurata 7.81 7.81 
3.91-
62.50 3.91-62.50 
aMIC at which 50 % of the isolates were inhibited (MIC50); 




Time kill assay of the chloroform extract from B. 
pandurata against S. pyogenes is demonstrated 
in Figure 1.  Complete killing of S. pyogenes 
cells treated with 4MIC, 2MIC, and MIC (MBC) of 
the extract occurred within 4, 8, and 12 h after 
treatment with the extract, respectively. The 
growth rate of 1/2MIC treated culture was lower 
than the control until 16 h and subsequently 
reached the same level as the control.  
 
Figure 1:  Time-kill curves of Streptococcus pyogenes 
NPRC 101 after treatment with the extract of 
Boesenbergia pandurata. 1/2MIC (□), MIC (■), 2MIC 
(▲), 4MIC (●), and 1 % DMSO was used as a control 




S. pyogenes cell lysis activity of the chloroform 
extract from B. pandurata is presented in Figure 
2. The treatment of the bacterial cells with the 
extract at 2MIC and 4MIC caused cell lysis.  
After 2 h at 2MIC and 4MIC of B. pandurata 
extract induced the cell lysis around 44% and 
76%, respectively. After 4 h until 24 h, the 
bacterial cells were lysed approximately 36-49% 
and 76-98% when treated with the extracts at 
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Figure 2:  Bacteriolytic activity of Boesenbergia 
pandurata extract against Streptococcus pyogenes 
NPRC 101. 1/2MIC (□), MIC (■), 2MIC (▲), 4MIC (●), 
and 1% DMSO (○). 
 
Enzyme and toxin inhibition  
 
The productions or activities of protease 
enzymes and streptolysins in the presence of the 
plant extract were calculated as degree of 
hydrolysis and haemolysis, respectively. For 
protease inhibition assay, at all concentrations of 
the extract, all isolates demonstrated degree of 
hydrolysis ranging from 1.39 - 1.65. The degree 
of hydrolysis in the control agar was 1.42 - 1.61. 
None of extracts produced total (the halo was 
absent) or partial inhibition (the halo was ≥50 %) 
when compared with the control (Figure 3). The 
streptolysin inhibition assay showed similar 
results (Figure 4). 
 
 
Figure 3:  The effect of Boesenbergia pandurata 
extract on streptolysins production by Streptococcus 
pyogenes. 1/2MIC ( ), 1/4MIC ( ), 1/8MIC ( ), 
1/16MIC ( ), 1/32MIC ( ), and 1 % DMSO ( ) was 
used as control. The degree of hydrolysis is indicated 
by the mean ± SD. 
 
Figure 4:  The effect of Boesenbergia pandurata 
extract on protease enzymes production by 
Streptococcus pyogenes. 1/2MIC ( ), 1/4MIC ( ), 
1/8MIC ( ), 1/16MIC ( ), 1/32MIC ( ), and 1%DMSO 
( ) was used as control. The degree of hydrolysis is 




The rhizome of B. pandurata has long been used 
as traditional Thai medicine for bacterial 
infections. From the antibacterial screening test  
against S. pyogenes by disc diffusion assay, the 
chloroform extract of B. pandurata produced a 
very narrow inhibition zone around 7 - 8 mm 
(data not shown).  However, it generated very 
good MIC and MBC values (3.91 - 62.50 µg/ml).  
This finding suggests that the active components 
against S. pyogenes in this plant are most likely 
to be slightly or non-polar molecules. Extract 
from non-polar solvent and oil from this plant 
have been reported to be effective against many 
bacteria [5,8], fungi, and yeasts [6].  
 
Isopanduratin A, an active compound from this 
plant, demonstrated antibacterial activity against 
many streptococci including S. mutans, S. 
sobrinus, S. sanguinis, and S. salivarius [11]. 
The MIC of isopanduratin A on Streptococcus 
spp. from the previous study was 4 µg/ml. The 
crude extract from this study showed 7.81 µg/ml 
(MIC90) on S. pyogenes. The MIC values of 
isopanduratin A and the crude extract are not 
significantly different. However, it is rather 
difficult to compare the inhibitory activity of this 
compound and the crud extract as the studies 
differ in the bacterial species used. Hence, the 
isolation for active compounds that responsible 
for anti-S. pyogenes is needed.  
 
To determine how quickly the extract from B. 
pandurata acts on S. pyogenes time-kill study 
was performed. Time-kill study is defined as the 
rate of killing by a fixed concentration of an 
antimicrobial agent and is one of the methods for 
determining tolerance. The extract of B. 
pandurata at concentrations of 4MIC, 2MIC, and 
MIC (MBC) demonstrated a ≥ 3 log10-cfu killing 
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(99.9 %) at 4, 8, 12 h, respectively. This extract 
exhibited a concentration-dependent killing 
profile. The time-kill activity of rhodomyrtone, an 
isolated active compound from Rhodomyrtus 
tomentosa, has been studied against S. 
pyogenes [20]. At the concentrations equivalence 
to 2MBC and 4MBC, the killing rate of B. 
pandurata extract was faster than rhodomyrtone.  
 
Recently, many studies have attempted to 
explain the mechanisms of action of some 
medicinal plant extracts on pathogenic bacteria. 
The essential oils from oregano, rosewood, 
thyme [21], and tea tree [18] have been reported 
to cause bacterial membrane damage and 
induce cell lysis. The essential oil from B. 
pandurata has been reported to altered 
permeability of the membrane of Escherichia coli 
[5]. Isopanduratin A from this plant has been 
demonstrated to damage the cell membrane and 
cell wall of S. mutans [11]. This present study 
revealed that treatment of S. pyogenes cells with 
B. pandurata extract resulted in cell lysis. A 
possible mechanism of action may be associated 
with cell wall and membrane damage. 
 
Proteases have long been considered as 
virulence factors for organisms as they are able 
to facilitate the spread of organism.  S. pyogenes 
produces, or at least have the potential to 
produce, a number of different proteolytic 
enzymes that can play important roles during 
infections [12]. Some medicinal plant extracts 
including, Helichrysum italicum and Nepeta 
cataria showed inhibitory effects on some 
bacterial enzymes that contribute to the 
pathogenic properties [19]. However, this 
present study revealed that the extract of B. 
pandurata at sub-inhibitory concentrations had 
no effect on the protease enzymes of S. 
pyogenes.  
 
S. pyogenes secretes two haemolysins, 
streptolysin O and streptolysin S. Both 
streptolysin O and S are classified as virulence 
factors of S. pyogenes. Abuharfeil et al. [22] 
reported that date fruit (Phoenix dactylifera) 
neutralized the haemolytic activity of the 
streptolysin O. The neutralization property of this 
extract was most probably due to stabilization of 
the erythrocyte membrane and inhibition of the 
streptolysin O enzyme. Nevertheless, the results 
from this study have demonstrated that all tested 
concentrations of the extract of B. pandurata had 




In summary, the extract of B. pandurata rhizome 
demonstrated good activity against all clinical 
isolates of S. pyogenes. The bacteriolytic activity 
of the extract indicated that a possible 
mechanism of action may be associated with cell 
wall and membrane damage. Our research is 
ongoing to investigate the active compounds in 
this plant as well as its antibacterial 
mechanisms. The isolated active compounds 
may have potential to be used as therapeutic 
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